共 40 条
[1]
Braunwald E., Control of myocardial oxygen consumption. Physiological and clinical considerations, Am J Cardiol, 27, pp. 416-432, (1971)
[2]
Gillam P., Use of propranolol in angina pectoris, Br Med J, 2, pp. 337-339, (1965)
[3]
Dagenais G.R., Pitt B., Ross R.S., Exercise tolerance in patients with angina pectoris. Daily variation and effects of erythrityl tetranitrate, propranolol and alprenolol, Am J Cardiol, 28, pp. 10-16, (1971)
[4]
Henry P.D., Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazem, Am J Cardiol, 46, pp. 1047-1058, (1980)
[5]
Josephson M.A., Singh B.N., Use of calcium antagonists in ventricular dysfunction, The American Journal of Cardiology, 55, pp. 81B-85B, (1985)
[6]
Vatner S.F., Hintze T.H., Effects of a calcium-channel antagonist on large and small coronary vessels in conscious dogs, Circulation, 66, pp. 579-587, (1982)
[7]
Nayler W., Dillon J.S., Daly M.J., Cellular sites of action of calcium antagonists and β-adrenoceptor blockers, Calcium antagonists and cardiovascular disease, pp. 181-192, (1984)
[8]
Heusch G., Deussen A., Schipke J., Et al., α<sub>1</sub> and α<sub>2</sub>-adrenoceptor-mediated vasoconstriction of large and small canine coronary arteries in vivo, J Cardiovasc Pharmacol, 6, pp. 961-968, (1984)
[9]
Schamhardt H.C., Verdouw P.D., Saxena P.R., Improvement of perfusion and function of ischemic porcine myocardium after reduction of heart rate by alinidine, J Cardiovasc Pharmacol, 3, pp. 728-738, (1981)
[10]
Dammgen J.W., Lamping K.A., Gross G.J., Actions of two new bradycardic agents, Journal of Cardiovascular Pharmacology, 7, pp. 71-79, (1985)